Erpenbach K, Derschum W, von Vietsch H
Abteilung Urologie, Bundeswehrzentralkrankenhaus Koblenz.
Urologe A. 1990 Jan;29(1):43-5.
Despite different treatment modalities, resistance to treatment is observed in 4-15% of patients with anogenital condylomata acuminata. A total of 16 patients with resistant condylomata acuminata or extended infection affecting an area of more than 6 cm2 were treated with a prospectively defined therapy entailing laser treatment and adjuvant systemic interferon-alpha 2B (3 x 1 MU/day for 7 days). Of the 16 patients, 13 (81%) were in complete remission after an 8-month period of follow up. The typical side-effects of interferon were attenuated in 80% of cases by simultaneous paracetamol (3 x 500 mg/day). The combination of laser treatment and adjuvant systemic interferon-alpha 2B seems to be highly effective in the treatment of resistant or extended condylomata acuminata. At present, these results are being tested for significance in a prospectively randomized study.
尽管采用了不同的治疗方式,但在4%至15%的尖锐湿患者中仍观察到治疗抵抗。共有16例尖锐湿疣治疗抵抗或感染范围超过6平方厘米的患者接受了一项前瞻性定义的治疗,该治疗包括激光治疗和辅助全身应用干扰素α-2B(3×1MU/天,共7天)。在这16例患者中,13例(81%)在8个月的随访期后完全缓解。在80%的病例中,同时服用对乙酰氨基酚(3×500mg/天)可减轻干扰素的典型副作用。激光治疗与辅助全身应用干扰素α-2B联合似乎在治疗尖锐湿疣抵抗或范围扩大方面非常有效。目前,这些结果正在一项前瞻性随机研究中检验其显著性。